Post-zygotic Point Mutations Are an Underrecognized Source of De Novo Genomic Variation.
Ontology highlight
ABSTRACT: De novo mutations are recognized both as an important source of genetic variation and as a prominent cause of sporadic disease in humans. Mutations identified as de novo are generally assumed to have occurred during gametogenesis and, consequently, to be present as germline events in an individual. Because Sanger sequencing does not provide the sensitivity to reliably distinguish somatic from germline mutations, the proportion of de novo mutations that occur somatically rather than in the germline remains largely unknown. To determine the contribution of post-zygotic events to de novo mutations, we analyzed a set of 107 de novo mutations in 50 parent-offspring trios. Using four different sequencing techniques, we found that 7 (6.5%) of these presumed germline de novo mutations were in fact
SUBMITTER: Acuna-Hidalgo R
PROVIDER: S-EPMC4571017 | biostudies-literature | 2015 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA